Scripps Institute Spin-Out Company Raises $3 Million

Myosin Therapeutics, a UF biotechnology company developing new medications to treat brain cancer and methamphetamine addiction, secured $3 million in seed funding from investors. The capital will be used to initiate multiple clinical trials this year, said co-founder and CEO Courtney Miller.

Based in Jupiter, Myosin is a spin-out of the Herbert Wertheim UF Scripps Institute, a research institute focused on developing neuroscience and oncology therapies

Read more about Scripps Institute Spin-Out Company Raises $3 Million($$).